Please complete the required fields below to register:

Matters of the Mind

The Importance of Diversity, Equity and Inclusion in Alzheimer's disease Research


This seminar will examine why it is important that study populations in clinical research reflect the diversity of the overall population, and what can happen when this is not the case. Our presenters will discuss historical and current barriers to research participation among people of color, and will share examples of innovative practices that are being employed to improve diversity in clinical studies, and especially in Alzheimer's disease - related studies.


Crystal Glover, Ph.D.
Assistant Professor, division of behavioral sciences, Rush Medical College and Social Psychologist
Rush Alzheimer's Disease Center

Crystal M. Glover, PhD is a social psychologist, mixed-methodologist, and health equity in aging researcher at the Rush Alzheimer’s Disease Center. She also leads the Center’s Outreach, Recruitment, and Engagement (ORE) Core and serves as an Assistant Professor in the Departments of Psychiatry and Behavioral Sciences (and) Neurological Sciences at Rush Medical College. ...

She received her doctorate in social psychology and neuropsychology from Howard University, and completed her postdoctoral research fellowship at Dartmouth Geisel School of Medicine. She later received the Carol T. Mowbray Early Career Research Award from the United States Psychiatric Rehabilitation Association before joining the Department of Preventive Medicine at Rush Medical College as a BMO Harris Bank Health Disparities Research Fellow. Glover later joined the faculty of the Rush Alzheimer’s Disease Center. Her areas of interest include health equity and health disparities; structural and psychosocial determinants of health including education, employment, housing, and purpose in life; intersectionality as a conceptual framework and methodology; and social cognitive processes such as attitudes, beliefs, and perceptions. She focuses on cognitive and healthy aging in underrepresented and understudied communities including Blacks and Latinos and employs mixed-methods research designs to address related research questions. Glover’s current NIH-funded research focuses on decision-making regarding brain donation among older adults representing racial, ethnic, and economic minoritized groups. Glover has widely published her work in peer-reviewed scientific journals and presented her research at international and national scientific meetings. Dr. Glover belongs to various professional groups, including The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART), working to address health disparities and facilitate health equity both nationally and locally.

Carl V. Hill, Ph.D., M.P.H.
Interim Chief Diversity & Inclusion Officer and Vice President, Scientific Engagement
Alzheimer's Association

Carl V. Hill, Ph.D., MPH, is currently serving as interim chief diversity and inclusion officer for the Alzheimer’s Association, overseeing strategic initiatives to strengthen the Association’s outreach to all populations, providing communities with resources and support to address the Alzheimer’s crisis. He is also the Association’s vice president, Scientific Engagement. ...

In this role, he leads strategic efforts to create global awareness of the Association’s international research program. In his role as interim chief diversity and inclusion officer, Dr. Hill is responsible for developing cross-functional partnerships with organizations to advance diversity and inclusion, with a focus on relationships that broaden the Association’s reach in previously underserved communities. Within the Association, he collaborates with human resources to attract talent and develop resources that champion staff diversity and a culture of inclusion.

As a leader on the medical science team, Dr. Hill leads outreach to a network of staff, volunteers and donors at more than 75 Association chapters in order to grow understanding of the Association’s role in accelerating Alzheimer’s research and share scientific updates. To advance the Association’s scientific agenda, he will disseminate knowledge of the organization’s research program at key events, and work cross-functionally to build programs related to public health and the engagement of physicians and other health care groups. 

Prior to joining the Association, Dr. Hill served as director, Office of Special Populations at the National Institutes on Aging (NIA). In his six years at the NIA, he led the development of the Health Disparities Research Framework, which stimulates studies focused on health disparities related to aging. Dr. Hill also directed the Butler-Williams Scholars Program, which provides yearly training for early-career investigators interested in aging research. 

Dr. Hill earned his Ph.D. from the University of Michigan School of Public Health, where he trained with the Center for Research on Ethnicity, Culture and Health (CRECH) and the Program for Research on Black Americans (PRBA). He is an alumnus of the National Medical Fellowships Inc./W.K. Kellogg Foundation Health Policy Fellowship Program. Dr. Hill holds a master’s degree in public health from Morehouse School of Medicine, and he received its Distinguished Alumnus Award in 2019. As a member of the Centers for Disease Control and Prevention's (CDC) Public Health Prevention Service, a training and leadership program, he helped to establish the Center for Bioethics in Research and Healthcare at Tuskegee University.


Matters of the Mind

Recording coming soon.

Brought to you by:

Alz Logo Alz Logo